Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYO10 |
| Upstream (Parents) |
|---|
| (<<) DDX18 → MYO10 |
| (<<) JUN → MYO10 |
| (<<) KRAS → MYO10 |
| (<<) NFAT5 → MYO10 |
| (<<) NFKBIA → MYO10 |
| (<<) NOTCH1 → MYO10 |
| (<<) PLAU → MYO10 |
| (<<) PLCG2 → MYO10 |
| (<<) PPRC1 → MYO10 |
| (<<) TARS → MYO10 |
| (<<) TCEAL1 → MYO10 |
| (<<) TCF7L1 → MYO10 |
| (<<) VANGL1 → MYO10 |
| Downstream (Children) |
|---|
| MYO10 → ABLIM1 (>>) |
| MYO10 → COIL (>>) |
| MYO10 → FOXC2 (>>) |
| MYO10 → GNAL (>>) |
| MYO10 → HSPC159 (>>) |
| MYO10 → KRT5 (>>) |
| MYO10 → LIMK1 (>>) |
| MYO10 → NCOR2 (>>) |
| MYO10 → PIK3R5 (>>) |
| MYO10 → SMAD5 (>>) |
| MYO10 → SYNJ2 (>>) |
| MYO10 → TMEM158 (>>) |
